therefore targeted G-MDSC enrichment as a potential mediator of immunosuppression in LKB1-deficient NSCLC and sensitized tumors to immunotherapy by overcoming MDSCs accumulation with all-trans retinoic acid in a LKB1-deficient NSCLC mouse model (59). This evidence concerns the gene STK11 and non-small cell lung carcinoma.